Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;110:3322-3328
Published online before print November 1, 2004, doi: 10.1161/01.CIR.0000147779.17602.18
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
110/21/3322    most recent
01.CIR.0000147779.17602.18v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hosaka, A.
Right arrow Articles by Nagawa, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hosaka, A.
Right arrow Articles by Nagawa, H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*GELATIN
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Angiogenesis
Right arrow Growth factors/cytokines

(Circulation. 2004;110:3322-3328.)
© 2004 American Heart Association, Inc.


Molecular Cardiology

Gelatin Hydrogel Microspheres Enable Pinpoint Delivery of Basic Fibroblast Growth Factor for the Development of Functional Collateral Vessels

Akihiro Hosaka, MD; Hiroyuki Koyama, MD; Toshihiro Kushibiki, MS; Yasuhiko Tabata, PhD; Nobuhiro Nishiyama, PhD; Tetsuro Miyata, MD; Hiroshi Shigematsu, MD; Tsuyoshi Takato, MD; Hirokazu Nagawa, MD

From the Department of Vascular Regeneration (A.H., H.K., N.N.), Graduate School of Medicine, University of Tokyo, Tokyo; the Division of Tissue Engineering (A.H., H.K., N.N., T.T.), University of Tokyo Hospital, Tokyo; the Division of Vascular Surgery (A.H., H.K., T.M., H.S., H.N.), Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo; and the Institute for Frontier Medical Sciences (T.K., Y.T.), Kyoto University, Kyoto, Japan.

Correspondence to Hiroyuki Koyama, MD, Department of Vascular Regeneration, Graduate School of Medicine, University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. E-mail hkoyama-tky{at}umin.ac.jp

Received June 28, 2004; revision received August 17, 2004; accepted August 26, 2004.

Background— Various growth factors promote collateral vessel development and are regarded as promising for the treatment of vascular occlusive diseases. However, an efficacious delivery system for them has yet to be established. We devised a strategy to augment functional collateral vessels by using acidic gelatin hydrogel microspheres (AGHMs) incorporating basic fibroblast growth factor (bFGF). The aim of the present study was to investigate the hypothesis that by intra-arterial (IA) administration of bFGF-impregnated AGHMs, bFGF could be delivered from AGHMs trapped in distal small-diameter vessels and thereby induce functional collateral vessels with an assured blood supply through the process of arteriogenesis.

Methods and Results— Various sizes of AGHMs (3 mg) incorporating 125I-labeled bFGF were injected into the left internal iliac artery of a rabbit model of hindlimb ischemia. Less than 50% of radioactivity accumulated in the ischemic hindlimb after injection of AGHMs that were 10 µm in diameter, whereas {approx}80% of radioactivity was counted in the ischemic limb after administration of 29- or 59-µm-diameter AGHMs. Calf blood pressure ratio and the ratio of regional blood flow of the bilateral hindlimbs immediately before and after IA administration of 29-µm–diameter AGHMs showed no significant change. Then we evaluated the function of the developed collateral vessels 28 days after IA administration of bFGF-impregnated, 29-µm-diameter AGHMs. IA administration of bFGF-impregnated AGHMs induced marked collateral vessel improvement compared with IA administration of phosphate buffered saline–treated AGHMs and intramuscular administration of bFGF-impregnated AGHMs.

Conclusions— IA administration of bFGF-impregnated, 29-µm-diameter AGHMs strongly induced functional collateral vessels without worsening ischemia, indicating the possible therapeutic usefulness of this approach.


Key Words: angiogenesis • collateral circulation • growth substances • ischemia • microspheres




This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
A. Seko, N. Nitta, A. Sonoda, S. Ohta, M. Takahashi, K. Murata, and Y. Tabata
Vascular Regeneration by Repeated Infusions of Basic Fibroblast Growth Factor in a Rabbit Model of Hind-Limb Ischemia
Am. J. Roentgenol., June 1, 2009; 192(6): W306 - W310.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
T. Sakai, N. Kuno, F. Takamatsu, E. Kimura, H. Kohno, K. Okano, and K. Kitahara
Prolonged Protective Effect of Basic Fibroblast Growth Factor-Impregnated Nanoparticles in Royal College of Surgeons Rats
Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3381 - 3387.
[Abstract] [Full Text] [PDF]